comparemela.com

Latest Breaking News On - Life sciences boku vienna - Page 1 : comparemela.com

Researchers from University of Natural Resources & Life Sciences Boku Vienna Describe Findings in Risk Management (Conflicting and Complementary Policy Goals As Sectoral Integration Challenge: an Analysis of Sectoral Interplay In Flood Risk ): Risk Management - Insurance News

Researchers from University of Natural Resources & Life Sciences Boku Vienna Describe Findings in Risk Management (Conflicting and Complementary Policy Goals As Sectoral Integration Challenge: an Analysis of Sectoral Interplay In Flood Risk ): Risk Management - Insurance News
insurancenewsnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insurancenewsnet.com Daily Mail and Mail on Sunday newspapers.

Modern anti-cancer drugs work via tiny molecular motions

 E-Mail Modern immunotherapeutic anti-cancer drugs support a natural mechanism of the immune system to inhibit the growth of cancer cells. They dock onto a specific receptor of the killer cell and prevent it from being switched off by the cancer cells. This is a complex molecular process, which is known but has not yet been fully understood. In a molecular dynamics study conducted by the group led by medical information scientist Wolfgang Schreiner and gynaecologists Heinz Kölbl and Georg Pfeiler from MedUni Vienna, working with biosimulation expert Chris Oostenbrink from the University of Natural Resources and Applied Life Sciences (Boku) Vienna, has now, for the first time, analysed this mechanism for the drugs nivolumab and pembrolizumab. It was found that tiny molecular motions are of key significance. The study has been published in the leading journal

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.